Early- to mid-term outcome of a short, cementless, titanium, flat, tapered stem for primary total hip arthroplasty: an independent series

CONCLUSIONS: The 7-year survivorship of the Taperloc Microplasty stem is within National Institute for Health and Care Excellence (NICE) guidelines. Patients ⩽65 years with osteoarthritis and Dorr A/B femoral morphology may be ideal candidates for THA with this stem. Femoral remodelling is common and not associated with adverse outcome.PMID:38073478 | DOI:10.1177/11207000231216421

Source: Hip International - December 11, 2023 Category: Orthopaedics Authors: Jonathan Bourget-Murray Brook Biniam Raman S Bhullar Paul Kim Wade Gofton Paul E Beaul é George Grammatopoulos Source Type: research